Acceleron  

Press Releases

All Releases
View Summary Acceleron to Participate in Two Healthcare Investor Conferences in February
Feb 1, 2017
PDF 9.6 KB
View Summary Acceleron Outlines Corporate Goals and Priorities for 2017
Jan 6, 2017
PDF 17.6 KB
View Summary Acceleron to Webcast Presentation at 35th Annual J.P. Morgan Healthcare Conference
Jan 4, 2017
PDF 9.6 KB
View Summary Acceleron Announces First Patient Treated in Phase 2 Trial of ACE-083 in Facioscapulohumeral Muscular Dystrophy
Dec 22, 2016
PDF 50.5 KB
View Summary Acceleron and Celgene Announce Updated Results from Phase 2 Studies of Luspatercept in Beta-Thalassemia Presented at the 58th Annual Meeting of the American Society of Hematology
Dec 5, 2016
PDF 122.9 KB
View Summary Acceleron and Celgene Announce Preliminary Results from an Investigator Initiated Phase 2 Study of Sotatercept in Myelofibrosis at the 58th Annual Meeting of the American Society of Hematology
Dec 5, 2016
PDF 74.6 KB
View Summary Acceleron and Celgene Announce Updated Results from Ongoing Phase 2 Studies of Luspatercept in Myelodysplastic Syndromes at the 58th Annual Meeting of the American Society of Hematology
Dec 4, 2016
PDF 84.3 KB
View Summary Acceleron Pharma to Host Conference Call and Webcast to Review Data Presented at the 58th American Society of Hematology Annual Meeting and Exposition
Nov 30, 2016
PDF 9.9 KB
View Summary Acceleron Pharma Reports Third Quarter 2016 Financial and Operational Results
Nov 3, 2016
PDF 24.7 KB
View Summary Acceleron Announces New Data Presentations at the 58th American Society of Hematology Annual Meeting and Exposition
Nov 3, 2016
PDF 52.5 KB
View Summary Acceleron to Present at Credit Suisse Healthcare Conference Monday, November 7, 2016
Nov 2, 2016
PDF 9.2 KB
View Summary Acceleron Pharma to Webcast Conference Call of Third Quarter 2016 Financial Results on November 3, 2016
Oct 27, 2016
PDF 9.5 KB
View Summary Acceleron to Host Educational Webcast on Facioscapulohumeral Muscular Dystrophy (FSHD) with Leading Researcher and Provide Overview of ACE-083 Phase 2 Trial
Oct 13, 2016
PDF 49.6 KB
View Summary Acceleron Announces Retirement of John Knopf as President and CEO; Habib Dable Named as Successor
Sep 27, 2016
PDF 14.3 KB
View Summary Acceleron to Participate in Three Healthcare Investor Conferences in September
Aug 31, 2016
PDF 9.7 KB
View Summary Acceleron Pharma Reports Second Quarter 2016 Financial and Operational Results
Aug 4, 2016
PDF 24.9 KB
View Summary Acceleron Pharma to Webcast Conference Call of Second Quarter 2016 Financial Results on August 4, 2016
Jul 28, 2016
PDF 9.5 KB
View Summary Acceleron Pharma Appoints Thomas McCourt to its Board of Directors
Jul 25, 2016
PDF 9.8 KB
View Summary Acceleron Announces ACE-083 Phase 1 Results at the 14th International Congress on Neuromuscular Diseases
Jul 8, 2016
PDF 53.5 KB
View Summary Acceleron Announces Presentation of ACE-083 Phase 1 Healthy Volunteer Data at the 14th International Congress on Neuromuscular Disease
Jun 29, 2016
PDF 12.4 KB
Showing 1-20 of 265 Page: 1 2 3 4 5 ... 14  Next 20